Behcet disease research in 2020 spanned topics in diagnosis, pharmacologic management and quality of life. We wrap up the year with 8 new study summaries.
Behçet disease (BD) research published in 2020 included guidelines for management during the COVID-19 pandemic and spanned topics from challenges in (and solutions for) BD pediatric diagnosis to a promising, cost-effective predictor of BD activity.
Following are highlights of 8 new studies, a concise summary now cataloged in the Patient Care Behçet Disease Topic Resource Center. You can visit the TRC by clicking on the link at the end of the slide show.
Atopic Dermatitis: The Pipeline and Clinical Approaches That Could Transform the Standard of Care
September 24th 2025Patient Care tapped the rich trove of research and expert perspective from the 2025 Revolutionizing Atopic Dermatitis meeting to create a snapshot of the AD care of the future.